Trials / Recruiting
RecruitingNCT05804331
The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- Western Sydney Local Health District · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To determine the long term outcomes of Endoscopic Submucosal Dissection (ESD), Endoscopic Full Thickness Resection (EFTR) and Submucosal-Tunnelling Endoscopic Resection (STER) for upper gastrointestinal neoplastic lesions
Detailed description
To collect prospective observational data on patients undergoing ESD, EFTR or STER for UGI neoplastic lesions * Lesion characteristics including histology * Procedural outcomes * Safety Outcomes * Efficacy outcomes
Conditions
- Cancer of Stomach
- Oesophageal Cancer
- Gastric Cancer
- Gastric Adenocarcinoma
- GI Cancer
- GIST
- Neuroendocrine Tumors
- Gastric Neoplasm
- Esophageal Neoplasms
Timeline
- Start date
- 2023-03-14
- Primary completion
- 2028-03-14
- Completion
- 2028-09-14
- First posted
- 2023-04-07
- Last updated
- 2025-03-27
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT05804331. Inclusion in this directory is not an endorsement.